Aurobindo

Activities: Ingredients

Trending Articles

  1. Lonza Capsules & Health Ingredients expands capsule manufacturing capacity in India and China New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari (IN) and Suzhou (CN), highlighting the long-term strategic commitment to...
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    How CDMOs can set a new gold standard when it comes to going green Sustainability is more than a feel-good initiative or a choice; it’s a strategic imperative. Not missing a beat, pharma companies have been making a concerted effort towards...
  3. Novo Holdings completes acquisition of Catalent Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark
  4. Resolving capping issues in tablet manufacturing Natoli explores the various causes of capping and the methods to prevent it
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    Industrial data mastery: navigating the 2025 landscape As industrial manufacturers contend with the ever-increasing volume and variety of operational data, the year ahead promises both complexity and opportunity

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

Related Content

Manufacturing

Aurobindo Pharma signs $25m respiratory drug development and commercialisation deal with global pharma company

The companies will co-develop and commercialise respiratory therapeutics, diversifying Aurobindo's current portfolio
Pharmaceutical

Indian pharma firms develop niche portfolios

They aim to take advantage of generic growth in the US over the next two years
Pharmaceutical

Indian generic manufacturers aim to enter the Japanese market

The penetration of generic drugs in Japan is a little more than 30% compared with more 80% in the US market
Media

Aurobindo's generic drug for osteoporosis approved by US FDA

The global osteoporosis drugs market is seeing significant growth due to a rising geriatric population and changing lifestyles
Finance

Aurobindo and Glenmark to get inflow of foreign capital

Deals underscore the importance given by the Indian government to strengthening healthcare in the country, by ensuring availability of drugs to the population at reasonable prices
Finance

Aurobindo divests stake in Australian subsidiary

Company also reaches settlement with Plethico over Natrol acquisition
Regulatory

Nearly 90,000 Gabapentin capsules are recalled by Aurobindo Pharma and Actavis

The capsules were manufactured at two plants in India
Subscribe now